Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

BACKGROUND: Advanced sarcoma is a group of heterogeneous disease with poor prognosis and poor efficacy of medical treatment. They represent a promising group of tumors to assess molecular-based therapy (MBT) strategy. PATIENTS AND METHODS: Genomic profiles of patients with advanced sarcoma included...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnaud-Coffin, Patrick, Brahmi, Mehdi, Vanacker, Hélène, Eberst, Lauriane, Tredan, Olivier, Attignon, Valery, Pissaloux, Daniel, Sohier, Emilie, Cassier, Philippe, Garin, Gwenaelle, Pérol, David, Blay, Jean-Yves, Dufresne, Armelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509228/
https://www.ncbi.nlm.nih.gov/pubmed/32950930
http://dx.doi.org/10.1016/j.tranon.2020.100870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509228/
https://www.ncbi.nlm.nih.gov/pubmed/32950930
http://dx.doi.org/10.1016/j.tranon.2020.100870

Ejemplares similares